Helical Structure of Recombinant Melittin.

J Phys Chem B

Department of Chemistry , State University of New York at Albany, Albany , New York 12222 , United States.

Published: January 2019

Melittin is an extensively studied, 26-residue toxic peptide from honey bee venom. Because of its versatility in adopting a variety of secondary (helix or coil) and quaternary (monomer or tetramer) structures in various environments, melittin has been the focus of numerous investigations as a model peptide in protein folding studies as well as in studies involving binding to proteins, lipids, and polysaccharides. A significant body of evidence supports the view that melittin binds to these macromolecules in a predominantly helical conformation, but detailed structural knowledge of this conformation is lacking. In this report, we present nuclear magnetic resonance (NMR)-based structural insights into the helix formation of recombinant melittin in the presence of trifluoroethanol (TFE): a known secondary structure inducer in peptides. These studies were performed at neutral pH, with micromolar amounts of the peptide. Using nuclear Overhauser effect (NOE)-derived distance restraints from three-dimensional NMR spectra, we determined the atomic resolution solution NMR structure of recombinant melittin bearing a TFE-stabilized helix. To circumvent the complications with structure determination of small peptides with high conformational flexibility, we developed a workflow for enhancing proton NOEs by increasing the viscosity of the medium. In the TFE-containing medium, recombinant monomeric melittin forms a long, continuous helical structure, which consists of the N- and C-terminal α-helices and the noncanonical 3-helix in the middle. The noncanonical 3-helix is missing in the previously solved X-ray structure of tetrameric melittin and the NMR structure of melittin in methanol. Melittin's structure in TFE-containing medium provides insights into melittin's conformational transitions, which are relevant to the peptide's interactions with its biological targets.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465175PMC
http://dx.doi.org/10.1021/acs.jpcb.8b08424DOI Listing

Publication Analysis

Top Keywords

recombinant melittin
12
melittin
9
helical structure
8
structure recombinant
8
nmr structure
8
tfe-containing medium
8
noncanonical 3-helix
8
structure
7
recombinant
4
melittin melittin
4

Similar Publications

Heterologous expressing melittin in a probiotic yeast to evaluate its function for promoting NSC-34 regeneration.

Appl Microbiol Biotechnol

October 2024

Department of Life Sciences, National Chung Hsing University, No. 145, Xing-Da Road, South District, Taichung City, 40227, Taiwan, ROC.

Melittin is a bioactive peptide and the predominant component in bee venom (BV), studied for its many medical properties, such as antibacterial, anti-inflammatory, anti-arthritis, nerve damage reduction, and muscle cell regeneration. Melittin is primarily obtained through natural extraction and chemical synthesis; however, both methods have limitations and cannot be used for mass production. This study established a heterologous melittin expression system in the probiotic yeast Kluyveromyces marxianus.

View Article and Find Full Text PDF

In previous studies, we developed a novel fusion protein named "melittin-MIL-2" which exhibited more anti-tumor activity. However, it remains unclear whether melittin-MIL-2 possesses antitumor immune effect on lung adenocarcinoma. In this study, the immune effect and mechanism of melittin-MIL-2 inhibiting the growth and invasion of lung adenocarcinoma will be investigated, in order to provide novel perspectives for the immunotherapy of lung cancer.

View Article and Find Full Text PDF

A novel recombinant adenovirus expressing apoptin and melittin genes kills hepatocellular carcinoma cells and inhibits the growth of ectopic tumor.

Invest New Drugs

August 2024

Key Laboratory of Smart Breeding (Co-construction by Ministry and Province), Ministry of Agriculture and Rural Affairs, Tianjin Agricultural University, Tianjin, 300392, China.

HCC is the most common fatal malignancy. Although surgical resection is the primary treatment strategy, most patients are not eligible for resection due to tumor heterogeneity, underlying liver disease, or comorbidities. Therefore, this study explores the possibility of multi-molecular targeted drug delivery in treating HCC.

View Article and Find Full Text PDF

The present work aimed to examine the intracellular antibacterial efficacy of Recombinant Lactobacillus acidophilus/antimicrobial peptides (AMPs) Melittin and Alyteserin-1a, specifically targeting Gram-negative bacteria. The first assessment was to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of Recombinant L. acidophilus/AMPs versus Gram-negative and Gram-positive bacteria.

View Article and Find Full Text PDF

Melittin analog p5RHH enhances recombinant adeno-associated virus transduction efficiency.

J Integr Med

January 2024

Faculty of Traditional Chinese Medicine, Naval Medical University, Shanghai 200043, China; Oncology Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai 200433, China. Electronic address:

Article Synopsis
  • Melittin and its derivatives are being explored to enhance gene delivery systems, particularly in improving the efficiency of recombinant adeno-associated virus (rAAV) vectors for liver cancer treatment.
  • Various melittin-derived peptides were tested for their effects on rAAV vector performance, revealing that the p5RHH-rAAV2 vector was notably effective in transducing resistant cell lines and showed promise in both in vitro and in vivo settings.
  • The study identified several mechanisms through which melittin analogs enhance gene delivery, particularly emphasizing the role of endosome acidification in facilitating transgene expression.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!